Novo Nordisk has asked the FDA to dam manufacture of compounded copies of copyright, arguing that it’s way too challenging to do safely. It’s the latest escalation inside a brewing war among pharmaceutical firms and compounders.Spinal columns from cadavers are transported to your processing facility in Indianapolis, where the bone marrow is ext